P1 The importance of PSA density in treatment planning for ISUP Grade 1 prostate cancer

P1 The importance of PSA density in treatment planning for ISUP Grade 1 prostate cancer

Saved in:

Bibliographic Details
Main Authors:	K. Kaufmanis, E. Bitina-Barlote, M. Rate, B. Sebre-Smagre, P. Vaganovs, E. Vjaters
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325001521
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

P54 Immunotherapy with Bacillus Calmette-Guérin (BCG) for intermediate- and high-risk patients: A retrospective study in a Latvian population
by: M. Rate, et al.
Published: (2025-07-01)

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings
by: Yiji Peng, et al.
Published: (2025-03-01)

PSA DENSITY - A MARKER FOR POORLY-DIFFERENTIATED PROSTATE CANCER
by: Tosho Ganev
Published: (2025-02-01)

A case of high-grade prostate cancer with low PSA levels
by: Jan Bociański, et al.
Published: (2025-09-01)

PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis
by: Yuchun Li, et al.
Published: (2025-07-01)

Combination of PSA density and MLR improves the diagnostic accuracy of prostate cancer
by: Feng Guo, et al.
Published: (2025-07-01)

ISUP grade upgrade prediction after radical prostatectomy: Role of Luteinizing Hormone to Testosterone ratio
by: Zhihua Pan, et al.
Published: (2025-07-01)

Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications
by: Patryk Patrzałek, et al.
Published: (2025-07-01)

Preoperative prediction of WHO/ISUP grade of ccRCC using intratumoral and peritumoral habitat imaging: multicenter study
by: Zhihui Chen, et al.
Published: (2025-05-01)

Association of Serum PSA, fPSA, and CEA Levels with Prognosis and Clinicopathological Characteristics in Prostate Cancer
by: Ahamed Y, et al.
Published: (2025-08-01)

A novel composite index of PSA and periprostatic adipose tissue quantification for enhancing high-grade prostate cancer prediction
by: Jie Xiong, et al.
Published: (2025-08-01)

A predictive model for WHO/ISUP pathologic grading of renal clear cell carcinoma based on CT radiomics: a multicenter study
by: Chunying Wu, et al.
Published: (2025-07-01)

Multimodal deep learning with MUF-net for noninvasive WHO/ISUP grading of renal cell carcinoma using CEUS and B-mode ultrasound
by: Yixin Zhu, et al.
Published: (2025-03-01)

Radiomics-Based Classification of Clear Cell Renal Cell Carcinoma ISUP Grade: A Machine Learning Approach with SHAP-Enhanced Explainability
by: María Aymerich, et al.
Published: (2025-05-01)

Biproximate ellipsoid formula with transrectal ultrasound: a superior method for PSA density in gray zone prostate cancer detection
by: Xin Wang, et al.
Published: (2025-08-01)

Robotic Prostatectomy Has a Superior Outcome in Larger Prostates and PSA Density Is a Strong Predictor of Biochemical Recurrence
by: S. Bishara, et al.
Published: (2014-01-01)

Characteristics studies of anti total PSA antibody's binding with prostate
by: Baghdad Science Journal
Published: (2005-09-01)

THE PROGNOSTIC VALUE OF BASELINE PSA BLOOD IN THE TREATMENT OF PROSTATE CANCER
by: A. A. Gritskevich, et al.
Published: (2017-02-01)

PSA AND ITS RELATION TOTHE DEGREE OF DIFFERENTIATION OF PROSTATE CANCER
by: B. Lazarov
Published: (2025-03-01)

A strategy to reduce unnecessary prostate biopsies in patients with tPSA >10 ng ml−1 and PI-RADS 1–3
by: Qi-Fei Dong, et al.
Published: (2025-07-01)

The relation of serum PSA and Gleason's grade in patients with prostacic carcinoma
by: Živković Slađana, et al.
Published: (2003-01-01)

PSA and Beyond: The Past, Present, and Future of Investigative Biomarkers for Prostate Cancer
by: Jeffrey Tosoian, et al.
Published: (2010-01-01)

Commentary on the commentary “On measurement error, PSA doubling time, and prostate cancer”
by: Lawrence L. Kupper, et al.
Published: (2025-06-01)

Predicting prostate cancer metastasis in Ghana: Comparison of multiparametric and PSA models.
by: Frank Obeng, et al.
Published: (2025-01-01)

PSA density as a predictor of long-term infectious complications during transurethral resection of the prostate: determining an optimal cut-off value
by: S. N. Ivanov, et al.
Published: (2024-03-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Secondary Analysis of PSA and BCR-Free Survival in Asian Prostate Cancer Patients
by: Gao X, et al.
Published: (2025-06-01)

PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT
by: A. T. Asratov, et al.
Published: (2017-12-01)

P21 Evaluating the impact of PSA density on clinically significant prostate cancer detection in PIRADS-3 lesions – a single-centre study
by: H. Safdar
Published: (2025-07-01)

Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning
by: Ērika Bitiņa-Barlote, et al.
Published: (2025-02-01)

A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer
by: Srilakshmi Srinivasan, et al.
Published: (2024-11-01)

Mouse Brain PSA-NCAM Levels Are Altered by Graded-Controlled Cortical Impact Injury
by: Craig S. Budinich, et al.
Published: (2012-01-01)

Allele-specific methylation of the PSA promoter in prostate cells: A new translational marker for the differential diagnosis of prostate cancer
by: Mikhail Baryshev, et al.
Published: (2025-05-01)

Comparison in prostate cancer diagnosis with PSA 4–10 ng/mL: radiomics-based model VS. PI-RADS v2.1
by: Chunxing Li, et al.
Published: (2024-10-01)

The Effect of Fructose Level and Prostate Specific Antigen (PSA) on Sperms Motility in InFertiled Men
by: Aiesha saadoun jassim, et al.
Published: (2023-01-01)

Diagnosing prostate cancer in the PSA gray zone through machine learning and transrectal ultrasound video
by: Qin Wu, et al.
Published: (2025-05-01)

PSA as the driving biomarker to manage low- and intermediate-risk prostate cancer patients in clinical practice
by: Enrico Ricevuto, et al.
Published: (2024-10-01)

Detection of prostate cancer in the PSA gray zone using prostate-specific antigen mass ratio combined with PI-RADS score
by: Weilin Li, et al.
Published: (2025-07-01)

Von Hippel-Lindau Syndrome: Diagnosis and Management of Hemangioblastoma and Pheochromocytoma
by: P. Vaganovs, et al.
Published: (2013-01-01)

PyPSA-Spain: An extension of PyPSA-Eur to model the Spanish energy system
by: Cristobal Gallego-Castillo, et al.
Published: (2025-07-01)